CA2613187A1 - Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody - Google Patents
Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody Download PDFInfo
- Publication number
- CA2613187A1 CA2613187A1 CA002613187A CA2613187A CA2613187A1 CA 2613187 A1 CA2613187 A1 CA 2613187A1 CA 002613187 A CA002613187 A CA 002613187A CA 2613187 A CA2613187 A CA 2613187A CA 2613187 A1 CA2613187 A1 CA 2613187A1
- Authority
- CA
- Canada
- Prior art keywords
- antibody
- therapeutic antibody
- target antigen
- sample
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05014618 | 2005-07-06 | ||
| EP05014618.2 | 2005-07-06 | ||
| EP06004447.6 | 2006-03-06 | ||
| EP06004447 | 2006-03-06 | ||
| PCT/EP2006/006524 WO2007003420A1 (en) | 2005-07-06 | 2006-07-05 | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2613187A1 true CA2613187A1 (en) | 2007-01-11 |
Family
ID=36922121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002613187A Abandoned CA2613187A1 (en) | 2005-07-06 | 2006-07-05 | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070009976A1 (https=) |
| EP (2) | EP1902315A1 (https=) |
| JP (1) | JP2008545145A (https=) |
| KR (1) | KR20080016939A (https=) |
| AR (1) | AR053948A1 (https=) |
| AU (1) | AU2006265275A1 (https=) |
| BR (1) | BRPI0612591A2 (https=) |
| CA (1) | CA2613187A1 (https=) |
| CR (1) | CR9635A (https=) |
| EC (1) | ECSP088081A (https=) |
| IL (1) | IL188317A0 (https=) |
| MA (1) | MA29730B1 (https=) |
| MX (1) | MX2008000277A (https=) |
| MY (1) | MY157955A (https=) |
| NO (1) | NO20076662L (https=) |
| NZ (1) | NZ564471A (https=) |
| RU (1) | RU2008103608A (https=) |
| TW (1) | TWI312864B (https=) |
| WO (1) | WO2007003420A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130056201A (ko) * | 2000-05-19 | 2013-05-29 | 제넨테크, 인크. | ＥｒｂＢ 길항제에 의한 암 치료요법에 대한 효과적인 반응의 가능성을 개선시키기 위한 유전자 검출 분석 |
| KR20140032004A (ko) | 2004-07-22 | 2014-03-13 | 제넨테크, 인크. | Ｈｅｒ２ 항체 조성물 |
| KR101134208B1 (ko) | 2004-10-01 | 2012-04-09 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 촬상 장치 및 그 방법 |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| EP1850874B1 (en) | 2005-02-23 | 2013-10-16 | Genentech, Inc. | Extending time to disease progression or survival in ovarian cancer patients using pertuzumab |
| PE20070207A1 (es) * | 2005-07-22 | 2007-03-09 | Genentech Inc | Tratamiento combinado de los tumores que expresan el her |
| US8358354B2 (en) | 2009-01-26 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical abberations |
| US8243157B2 (en) | 2006-02-07 | 2012-08-14 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical aberrations |
| MX2009008981A (es) | 2007-03-02 | 2009-09-02 | Genentech Inc | Prediccion de respuesta a un inhibidor her. |
| TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物 |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| WO2013055874A2 (en) | 2011-10-14 | 2013-04-18 | Genentech, Inc. | Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| KR101327542B1 (ko) * | 2012-03-15 | 2013-11-08 | 광주과학기술원 | 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법 |
| AU2012232949B2 (en) * | 2012-09-28 | 2014-07-03 | Willowtree Holdings Pty Ltd | Temporary bulkhead |
| RU2019115089A (ru) | 2013-04-16 | 2019-06-11 | Дженентек, Инк. | Варианты пертузумаба и их аналитическая характеристика |
| JP2017513901A (ja) | 2014-04-25 | 2017-06-01 | ジェネンテック， インコーポレイテッド | トラスツズマブ−ｍｃｃ−ｄｍ１及びペルツズマブにより早期の乳癌を処置する方法 |
| US11406715B2 (en) | 2015-05-30 | 2022-08-09 | Genentech, Inc. | Methods of treating HER2-positive metastatic breast cancer |
| WO2017087280A1 (en) | 2015-11-16 | 2017-05-26 | Genentech, Inc. | Methods of treating her2-positive cancer |
| AU2017387909A1 (en) | 2016-12-28 | 2019-06-27 | Genentech, Inc. | Treatment of advanced HER2 expressing cancer |
| SG11201905622VA (en) | 2017-01-17 | 2019-08-27 | Genentech Inc | Subcutaneous her2 antibody formulations |
| US11077189B2 (en) | 2017-03-02 | 2021-08-03 | Genentech Inc. | Adjuvant treatment of HER2-positive breast cancer |
| EP3615695A1 (en) | 2017-04-24 | 2020-03-04 | Genentech, Inc. | Erbb2/her2 mutations in the transmebrane or juxtamembrane domain |
| AU2020456731A1 (en) | 2020-06-29 | 2023-01-05 | F. Hoffmann-La Roche Ag | Pertuzumab plus trastuzumab fixed dose combination |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP1400536A1 (en) * | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1993021319A1 (en) | 1992-04-08 | 1993-10-28 | Cetus Oncology Corporation | HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES |
| CN101412758A (zh) | 1996-10-18 | 2009-04-22 | 基因技术股份有限公司 | 抗ErbB2抗体 |
| US7718387B2 (en) * | 2001-09-20 | 2010-05-18 | Board Of Regents, The University Of Texas System | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| ES2392525T3 (es) * | 2002-07-15 | 2012-12-11 | F. Hoffmann-La Roche Ag | Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4 |
-
2006
- 2006-06-29 MY MYPI20063118A patent/MY157955A/en unknown
- 2006-06-29 US US11/477,772 patent/US20070009976A1/en not_active Abandoned
- 2006-07-04 TW TW095124248A patent/TWI312864B/zh active
- 2006-07-04 AR ARP060102872A patent/AR053948A1/es not_active Application Discontinuation
- 2006-07-05 CA CA002613187A patent/CA2613187A1/en not_active Abandoned
- 2006-07-05 EP EP06754671A patent/EP1902315A1/en not_active Withdrawn
- 2006-07-05 RU RU2008103608/15A patent/RU2008103608A/ru unknown
- 2006-07-05 NZ NZ564471A patent/NZ564471A/en unknown
- 2006-07-05 EP EP10157725A patent/EP2194380A3/en not_active Withdrawn
- 2006-07-05 WO PCT/EP2006/006524 patent/WO2007003420A1/en not_active Ceased
- 2006-07-05 KR KR1020087000259A patent/KR20080016939A/ko not_active Ceased
- 2006-07-05 JP JP2008519853A patent/JP2008545145A/ja active Pending
- 2006-07-05 AU AU2006265275A patent/AU2006265275A1/en not_active Abandoned
- 2006-07-05 BR BRPI0612591-3A patent/BRPI0612591A2/pt not_active IP Right Cessation
- 2006-07-05 MX MX2008000277A patent/MX2008000277A/es not_active Application Discontinuation
-
2007
- 2007-12-20 IL IL188317A patent/IL188317A0/en unknown
- 2007-12-21 CR CR9635A patent/CR9635A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076662A patent/NO20076662L/no not_active Application Discontinuation
-
2008
- 2008-01-04 EC EC2008008081A patent/ECSP088081A/es unknown
- 2008-02-01 MA MA30617A patent/MA29730B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1902315A1 (en) | 2008-03-26 |
| AU2006265275A1 (en) | 2007-01-11 |
| TWI312864B (en) | 2009-08-01 |
| WO2007003420A1 (en) | 2007-01-11 |
| ECSP088081A (es) | 2008-02-20 |
| MA29730B1 (fr) | 2008-09-01 |
| EP2194380A3 (en) | 2010-07-14 |
| IL188317A0 (en) | 2008-04-13 |
| KR20080016939A (ko) | 2008-02-22 |
| AR053948A1 (es) | 2007-05-23 |
| EP2194380A2 (en) | 2010-06-09 |
| CR9635A (es) | 2008-02-20 |
| TW200741203A (en) | 2007-11-01 |
| NZ564471A (en) | 2010-04-30 |
| MY157955A (en) | 2016-08-30 |
| US20070009976A1 (en) | 2007-01-11 |
| MX2008000277A (es) | 2008-03-24 |
| RU2008103608A (ru) | 2009-08-20 |
| NO20076662L (no) | 2008-04-03 |
| BRPI0612591A2 (pt) | 2010-11-23 |
| JP2008545145A (ja) | 2008-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070009976A1 (en) | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody | |
| US7279287B2 (en) | Analytical method | |
| JP2011039072A (ja) | 実験動物における治療抗体の検出 | |
| US20180113127A1 (en) | Immunoassay method and assay reagent used in said method | |
| KR102431142B1 (ko) | L-fabp의 면역학적 측정 방법 및 해당 방법에 사용되는 측정 시약 | |
| EP2707720B1 (en) | Diagnosis and prognosis of triple negative breast and ovarian cancer | |
| CN101213450A (zh) | 不论存在或不存在相对应的治疗用抗体而检测靶抗原 | |
| Fetsch et al. | The effects of antibody clone and pretreatment method on the results of HER2 immunostaining in cytologic samples of metastatic breast cancer: A query and a review of the literature | |
| HK1115446A (en) | Detecting of a target antigen irrespective of the presenace or absence of a corresponding therapeutic antibody | |
| US20090029394A1 (en) | Novel Assay for the Detection of an Antibody Bound to a Cell Membrane Receptor | |
| US20250244337A1 (en) | Compositions and methods for identifying subjects who may benefit from treatment with therapeutic agents | |
| CN113125743B (zh) | 一种超敏心肌肌钙蛋白i检测方法和试剂盒 | |
| CN117783526A (zh) | 一种定量检测生物体液中热带念珠菌烯醇化酶的方法 | |
| WO2023191046A1 (ja) | Ｈｒｇに対するモノクローナル抗体を用いたｈｒｇの測定方法 | |
| CN121293356A (zh) | FRα单克隆抗体及其应用 | |
| Ahmed | Elucidation of the Principles | |
| JPWO2006051632A1 (ja) | 抗デクチン−１モノクローナル抗体を産生するハイブリドーマ | |
| Coons | Introduction to Immunohistochemistry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |